PMV Pharmaceuticals, Inc. short interest in 2024
In 2024, PMV Pharmaceuticals, Inc.'s disclosed short interest ran from 3.02% of shares outstanding on 12 Jan 2024 to 2.60% on 31 Dec 2024, a change of -0.42 percentage points. The year's high was 5.48% on 30 Apr 2024 and its low 1.64% on 31 Oct 2024, averaging 3.25% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.33 days on 13 Sep 2024. Full history: PMV Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 3.02% (12 Jan 2024)
- End of year
- 2.60% (31 Dec 2024)
- Change
- -0.42 pp
- High
- 5.48% (30 Apr 2024)
- Low
- 1.64% (31 Oct 2024)
- Average
- 3.25%
- Highest days to cover
- 8.33 (13 Sep 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 3.02% | 4.38 | |
| 31 Jan 2024 | 3.42% | 3.74 | |
| 15 Feb 2024 | 3.60% | 2.92 | |
| 29 Feb 2024 | 3.86% | 5.14 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 4.39% | 2.70 | |
| 28 Mar 2024 | 5.06% | 4.46 | |
| 15 Apr 2024 | 5.41% | 5.01 | |
| 30 Apr 2024 | 5.48% | 8.24 | |
| 15 May 2024 | 5.00% | 4.22 | 10-Q filed, results (8-K) |
| 31 May 2024 | 4.96% | 7.26 | |
| 14 Jun 2024 | 4.91% | 4.57 | |
| 28 Jun 2024 | 4.35% | 2.38 | |
| 15 Jul 2024 | 2.26% | 4.12 | |
| 31 Jul 2024 | 2.08% | 4.85 | |
| 15 Aug 2024 | 2.11% | 4.40 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 2.04% | 4.36 | |
| 13 Sep 2024 | 2.05% | 8.33 | |
| 30 Sep 2024 | 2.03% | 4.76 | |
| 15 Oct 2024 | 1.89% | 5.53 | |
| 31 Oct 2024 | 1.64% | 4.07 | |
| 15 Nov 2024 | 1.64% | 4.32 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 1.71% | 7.67 | |
| 13 Dec 2024 | 2.53% | 4.77 | |
| 31 Dec 2024 | 2.60% | 7.83 |
See also: PMV Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.